Inmagene Biopharmaceutical ("Inmagene") and HUTCHMED (China) Limited ("HUTCHMED") announce that the first participant, based in the United States, was dosed in a global Phase...
Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the...
Amgen announced three new data sets from its thoracic oncology portfolio that will be presented at the International Association for the Study of Lung...
